These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24748395)

  • 1. Dihydroartemisinin-piperaquine vs. artemether-lumefantrine for first-line treatment of uncomplicated malaria in African children: a cost-effectiveness analysis.
    Pfeil J; Borrmann S; Tozan Y
    PLoS One; 2014; 9(4):e95681. PubMed ID: 24748395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Economic Evaluation of the Posttreatment Prophylactic Effect of Dihydroartemisinin-Piperaquine Versus Artemether-Lumefantrine for First-Line Treatment of Plasmodium falciparum Malaria Across Different Transmission Settings in Africa.
    Pfeil J; Borrmann S; Bassat Q; Mulenga M; Talisuna A; Tozan Y
    Am J Trop Med Hyg; 2015 Nov; 93(5):961-6. PubMed ID: 26240155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa.
    Yavo W; Faye B; Kuete T; Djohan V; Oga SA; Kassi RR; Diatta M; Ama MV; Tine R; Ndiaye JL; Evi JB; Same-Ekobo A; Faye O; Koné M
    Malar J; 2011 Jul; 10():198. PubMed ID: 21774826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda.
    Yeka A; Dorsey G; Kamya MR; Talisuna A; Lugemwa M; Rwakimari JB; Staedke SG; Rosenthal PJ; Wabwire-Mangen F; Bukirwa H
    PLoS One; 2008 Jun; 3(6):e2390. PubMed ID: 18545692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children aged less than five years: results of an open-label, randomized, single-centre study.
    Ogutu BR; Onyango KO; Koskei N; Omondi EK; Ongecha JM; Otieno GA; Obonyo C; Otieno L; Eyase F; Johnson JD; Omollo R; Perkins DJ; Akhwale W; Juma E
    Malar J; 2014 Jan; 13():33. PubMed ID: 24472156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of dihydroartemisinin-piperaquine compared with artemether-lumefantrine for treating uncomplicated malaria in children at a district hospital in Tanzania.
    Mori AT; Ngalesoni F; Norheim OF; Robberstad B
    Malar J; 2014 Sep; 13():363. PubMed ID: 25223864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Budget Impact Analysis of Using Dihydroartemisinin-Piperaquine to Treat Uncomplicated Malaria in Children in Tanzania.
    Mori AT; Norheim OF; Robberstad B
    Pharmacoeconomics; 2016 Mar; 34(3):303-14. PubMed ID: 26521172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children.
    Arinaitwe E; Sandison TG; Wanzira H; Kakuru A; Homsy J; Kalamya J; Kamya MR; Vora N; Greenhouse B; Rosenthal PJ; Tappero J; Dorsey G
    Clin Infect Dis; 2009 Dec; 49(11):1629-37. PubMed ID: 19877969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of early vomiting among infants and young children treated with dihydroartemisinin-piperaquine compared with artemether-lumefantrine for uncomplicated malaria.
    Creek D; Bigira V; Arinaitwe E; Wanzira H; Kakuru A; Tappero J; Kamya MR; Dorsey G; Sandison TG
    Am J Trop Med Hyg; 2010 Oct; 83(4):873-5. PubMed ID: 20889882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of the efficacy and tolerability of dihydroartemisinin-piperaquine-trimethoprim versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroon, Ivory Coast and Senegal.
    Menan H; Faye O; Same-Ekobo A; Oga AS; Faye B; Kiki Barro CP; Kuete T; N'diaye JL; Vicky AM; Tine R; Yavo W; Kane D; Kassi KF; Kone M
    Malar J; 2011 Jul; 10():185. PubMed ID: 21740570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malaria transmission after artemether-lumefantrine and dihydroartemisinin-piperaquine: a randomized trial.
    Sawa P; Shekalaghe SA; Drakeley CJ; Sutherland CJ; Mweresa CK; Baidjoe AY; Manjurano A; Kavishe RA; Beshir KB; Yussuf RU; Omar SA; Hermsen CC; Okell L; Schallig HD; Sauerwein RW; Hallett RL; Bousema T
    J Infect Dis; 2013 Jun; 207(11):1637-45. PubMed ID: 23468056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria.
    Muhindo MK; Kakuru A; Jagannathan P; Talisuna A; Osilo E; Orukan F; Arinaitwe E; Tappero JW; Kaharuza F; Kamya MR; Dorsey G
    Malar J; 2014 Jan; 13():32. PubMed ID: 24468007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children.
    Nambozi M; Van Geertruyden JP; Hachizovu S; Chaponda M; Mukwamataba D; Mulenga M; Ubben D; D'Alessandro U
    Malar J; 2011 Feb; 10():50. PubMed ID: 21352609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated malaria among children in western Kenya.
    Agarwal A; McMorrow M; Onyango P; Otieno K; Odero C; Williamson J; Kariuki S; Kachur SP; Slutsker L; Desai M
    Malar J; 2013 Jul; 12():254. PubMed ID: 23870627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of dihydroartemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali.
    Dama S; Niangaly H; Djimde M; Sagara I; Guindo CO; Zeguime A; Dara A; Djimde AA; Doumbo OK
    Malar J; 2018 Oct; 17(1):347. PubMed ID: 30290808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal outcomes in a cohort of Ugandan children randomized to artemether-lumefantrine versus dihydroartemisinin-piperaquine for the treatment of malaria.
    Wanzira H; Kakuru A; Arinaitwe E; Bigira V; Muhindo MK; Conrad M; Rosenthal PJ; Kamya MR; Tappero JW; Dorsey G
    Clin Infect Dis; 2014 Aug; 59(4):509-16. PubMed ID: 24825870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria among Children in Western Kenya, 2016 to 2017.
    Westercamp N; Owidhi M; Otieno K; Chebore W; Buff AM; Desai M; Kariuki S; Samuels AM
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0020722. PubMed ID: 36036611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria among children in Africa: a systematic review and meta-analysis of randomized control trials.
    Assefa DG; Yismaw G; Makonnen E
    Malar J; 2021 Aug; 20(1):340. PubMed ID: 34384431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.